baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Soc. Generale Call 110 MRK 16.01..../ DE000SY7A0N2 /

10/9/2024 8:57:50 AM	Chg.-0.02	Bid10:00:44 PM	Ask10:00:44 PM	Underlying	Strike price	Expiration date	Option type
1.25EUR	-1.57%	- Bid Size: -	- Ask Size: -	Merck and Co Inc	110.00 USD	1/16/2026	Call

GlobeNewswire 7/31 Vaccinex Reports Positive Data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease

TeleTrader 7/30 Merck's Q2 sales up 7% to $16.1 billion

GlobeNewswire 7/17 Vaccinex to report topline data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease a...

TeleTrader 7/1 US closes higher after data

GlobeNewswire 6/27 Verizon elects Caroline A. Litchfield to its Board of Directors

GlobeNewswire 6/26 COUR Pharmaceuticals Appoints Tim Walbert to its Board of Directors

GlobeNewswire 6/11 Biora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next...

GlobeNewswire 6/6 Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepin...

GlobeNewswire 5/30 Monte Rosa Therapeutics Announces Leadership Team Promotions

TeleTrader 5/28 US markets turn to losses, Dow plunges 330 points

GlobeNewswire 5/28 Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD

GlobeNewswire 5/23 IO Biotech to Present at Jefferies Global Healthcare Conference

GlobeNewswire 5/23 atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors

GlobeNewswire 5/16 Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 5/14 IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights

GlobeNewswire 5/8 C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights

GlobeNewswire 4/25 American Kidney Fund Launches National Kidney Health Equity Media Campaign

TeleTrader 4/25 Merck's Q1 sales rise by 9% to $15.8 billion

GlobeNewswire 4/24 IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Onc...

GlobeNewswire 4/18 The New York Academy of Medicine Announces New Board of Trustee Members

GlobeNewswire 4/15 IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness

GlobeNewswire 4/9 IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer...

GlobeNewswire 4/5 IO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business Officer

GlobeNewswire 4/3 TOMI Environmental Solutions Receives Gold Safety Award from Highwire

GlobeNewswire 4/2 Vaccinex Reports 2023 Financial Results and Provides Corporate Update

Soc. Generale Call 110 MRK 16.01..../ DE000SY7A0N2 /

If you wish to receive reply to your feedback, please provide your email address.